Plandaí Biotechnology, Inc. (PLPL)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Plandaí Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '16 Sep 30, 2016 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 | Jun '13 Jun 30, 2013 | Jun '12 Jun 30, 2012 | 2011 |
Cash & Equivalents | 0.02 | 0.01 | 0.03 | 0.16 | 0.5 | 0.01 | Upgrade
|
Cash & Short-Term Investments | 0.02 | 0.01 | 0.03 | 0.16 | 0.5 | 0.01 | Upgrade
|
Cash Growth | 297.32% | -61.58% | -78.50% | -68.67% | 9659.72% | 2837.93% | Upgrade
|
Accounts Receivable | 0.02 | 0.04 | 0.02 | 0.01 | 0.01 | - | Upgrade
|
Receivables | 0.02 | 0.04 | 0.02 | 0.43 | 0.01 | - | Upgrade
|
Inventory | 0.06 | 0.07 | 0 | 0 | 0.01 | - | Upgrade
|
Prepaid Expenses | 0.05 | 0.07 | 0.27 | 0.1 | - | - | Upgrade
|
Other Current Assets | - | -0 | - | - | - | - | Upgrade
|
Total Current Assets | 0.16 | 0.18 | 0.33 | 0.69 | 0.52 | 0.01 | Upgrade
|
Property, Plant & Equipment | 6.5 | 6.08 | 8.01 | 8.39 | 7.92 | 0.22 | Upgrade
|
Long-Term Accounts Receivable | 0.1 | 0.12 | 0.09 | - | - | - | Upgrade
|
Other Long-Term Assets | 0.07 | 0.06 | 0.08 | 0.13 | 0.39 | 5.84 | Upgrade
|
Total Assets | 6.83 | 6.45 | 8.5 | 9.21 | 8.84 | 6.06 | Upgrade
|
Accounts Payable | 0.7 | 0.73 | 0.38 | 0.14 | 0.66 | 0.06 | Upgrade
|
Accrued Expenses | 0.86 | 0.74 | 0.29 | 0.04 | 0.09 | 0.03 | Upgrade
|
Short-Term Debt | 0.14 | 0.2 | - | 0.01 | 0.1 | - | Upgrade
|
Current Portion of Long-Term Debt | 14.95 | 14.08 | 14.53 | 3.03 | - | - | Upgrade
|
Other Current Liabilities | 0.86 | 1.02 | - | 0.02 | 0.05 | 0.01 | Upgrade
|
Total Current Liabilities | 17.5 | 16.77 | 15.19 | 3.25 | 0.9 | 0.1 | Upgrade
|
Long-Term Debt | - | - | - | 8.73 | 10.43 | 6.25 | Upgrade
|
Long-Term Leases | 1.74 | 1.53 | 1.51 | 1.33 | 0.99 | 0.59 | Upgrade
|
Other Long-Term Liabilities | 0.14 | 0.13 | 0.16 | - | 0 | - | Upgrade
|
Total Liabilities | 19.39 | 18.43 | 16.87 | 13.31 | 12.32 | 6.94 | Upgrade
|
Common Stock | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 31.62 | 30.85 | 30.12 | 23.88 | 7.83 | 7.89 | Upgrade
|
Retained Earnings | -41.7 | -40.69 | -36.31 | -26.73 | -10.9 | -8.72 | Upgrade
|
Comprehensive Income & Other | -0.22 | 0.01 | -0.38 | 0.06 | 0.43 | 0 | Upgrade
|
Total Common Equity | -10.28 | -9.8 | -6.54 | -2.78 | -2.63 | -0.81 | Upgrade
|
Minority Interest | -2.27 | -2.18 | -1.82 | -1.33 | -0.86 | -0.08 | Upgrade
|
Shareholders' Equity | -12.55 | -11.98 | -8.36 | -4.1 | -3.48 | -0.88 | Upgrade
|
Total Liabilities & Equity | 6.83 | 6.45 | 8.5 | 9.21 | 8.84 | 6.06 | Upgrade
|
Total Debt | 16.83 | 15.81 | 16.04 | 13.1 | 11.52 | 6.84 | Upgrade
|
Net Cash (Debt) | -16.81 | -15.8 | -16.01 | -12.95 | -11.02 | -6.83 | Upgrade
|
Net Cash Per Share | -0.09 | -0.09 | -0.12 | -0.11 | -0.10 | -0.07 | Upgrade
|
Filing Date Shares Outstanding | 243.63 | 187.53 | 178.24 | 131.01 | 106.27 | 110.9 | Upgrade
|
Total Common Shares Outstanding | 243.63 | 187.53 | 164.42 | 131.01 | 106.27 | 110.9 | Upgrade
|
Working Capital | -17.34 | -16.59 | -14.87 | -2.57 | -0.38 | -0.1 | Upgrade
|
Book Value Per Share | -0.04 | -0.05 | -0.04 | -0.02 | -0.02 | -0.01 | Upgrade
|
Tangible Book Value | -10.28 | -9.8 | -6.54 | -2.78 | -2.63 | -0.81 | Upgrade
|
Tangible Book Value Per Share | -0.04 | -0.05 | -0.04 | -0.02 | -0.02 | -0.01 | Upgrade
|
Machinery | - | 6.45 | 7.89 | 0.4 | - | - | Upgrade
|
Construction In Progress | - | - | - | 7.56 | - | - | Upgrade
|
Leasehold Improvements | - | 0.66 | 0.75 | 0.71 | - | - | Upgrade
|
Updated Mar 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.